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ABSTRACT
We described the case of a 23-year-old Nepalese man with seropositive rheumatoid arthritis and abnormal x-ray findings, found to be due to 
a very rare bone disease: Camurati Engelmann disease or progressive diaphyseal dysplasia (PDD). This is the first case reported in the Gulf 
area, although approximately 300 cases have been described worldwide. These patients usually present with limb pain and easy fatigability. 
Our patient first presented with bilateral, symmetrical inflammatory polyarthritis involving the knees, ankles and wrists but sparing the 
hands and feet. The diagnosis of PDD in our case was based on the classic radiological findings and a bone scan.
LEARNING POINTS
• Rheumatoid arthritis is a common condition with typical radiological findings.
• Any unusual radiological finding should be carefully assessed and explained.
• In our case the unusual findings were due to progressive diaphyseal dysplasia. 
KEYWORDS
Camurati Engelmann disease, rheumatoid arthritis
CASE REPORT 
A 23-year-old Nepalese man presented with bilateral symmetrical joint pain and swelling involving his knees, ankles and wrists, but sparing 
the small joints of his hands and feet, and associated with significant early morning stiffness. There was no history of skin rash, fever or 
shortness of breath and no back, chest or abdominal pain. 
On examination, the patient had marked swelling of the knees, ankles and wrists with tenderness. There were large knee effusions bilaterally 
(Fig. 1). The small joints of the hands and feet were not swollen or tender, but the hands and feet including the fingers and toes were enlarged 
with clubbing. There were no oral ulcers, eye redness, or back or sacroiliac joint tenderness. 
Investigations
CBCs, renal, liver and bone profiles were all normal. The inflammatory markers were elevated (ESR 51 and CRP 56), and the positive anti-
CCP antibody was present. Synovial fluid analysis revealed non-inflammatory fluid with a WBC of 355 with lymphocyte predominance.
X-rays showed diffuse irregular cortical bone thickening and mild fusiform bony enlargement in the diaphyseal region of the long bones, with 
sparing of the epiphyses, which is characteristic of PDD (Figs. 2–4). A bone scan showed an isolated increase in radiotracer uptake involving 
the diaphyseal regions in a symmetrical fashion (Fig. 5).
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The patient was started on oral methotrexate (MTX) with folic acid in addition to oral prednisolone 5 mg daily. However, response to 
treatment was minimal with persistent joint pain and swelling.
Figure 1. Bilateral knee swelling with effusion
Figure 2. Femur X-ray showing generalized symmetrical mild fusiform 
enlargement and cortical thickening involving the diaphysis of the right and 
left femur (red arrows), sparing the epiphyses. 
Figure 3. X-ray of the right leg showing symmetrical enlargement and cortical 
thickening involving the diaphysis of the tibia and fibula (red arrows), sparing the 
epiphyseal region, which is classic of progressive diaphyseal dysplasia (Camurati-
Engelman's disease). Similar changes were found in the other legthe synovial 
membrane and structural alterations of the tibia, talus and calcaneus with 
several chondromatosis bodies in the anterior part of the tibiotalar joint
Figure 4. Right knee showing symmetrical enlargement and cortical 
thickening involving the diaphysis of the visualized bones, with knee effusion.
the anterior part of the tibiotalar joint
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DISCUSSION
PDD is very rare[1,2]. It is most likely caused by increased periosteal bone formation with decreased endosteal resorption in the long bones, 
which is evidenced by thickening of the diaphyseal area together with a narrowed medullary canal[3]. The disease is associated with mutations 
in the TGFB1 gene[5], but not all patients with the disease have a mutation. Therefore, it was proposed that the disease be classified as type I 
(MIM 131300) when a mutation in TGFB1 is identified and as type II (MIM 606631) if the mutation is not found[6]. Although most cases are 
familial, some sporadic cases have been reported[7–9]. The classic radiographic findings include symmetrical hyperostosis and endostosis of 
the diaphysis of the long bones, and to a lesser extent of the metaphysis. The lower extremities are usually more often involved than the 
upper extremities[3]. An isotope bone scan usually shows uptake in the diaphysis, which finding can also be found in some members of the 
affected family with no clinical or radiological indication of the disease[10]. Our case demonstrated all the classic radiographic and bone scan 
findings for PDD. 
In the majority of cases, inflammatory markers should be within normal limits, but occasionally can be raised[11,12], as in our patient. In this 
case, the presence of inflammatory arthritis, which is not typical for PDD, should be further explored. Our patient clearly has seropositive 
RA, which is a much more common condition. We do not think that there is an association between PDD and rheumatoid arthritis (RA) as a 
rare disease such as PDD could incidentally co-occur with another common condition such as RA. 
The management of PDD and RA is totally different. Treatment for PDD includes anti-resorptive agents such as pamidronate, steroids, 
aspirin and NSAIDs. They are used mainly for pain, with variable success, but have no effect on the radiographic and isotopic features of the 
disease[13–16]. Our patient was treated with MTX and folic acid for his RA with only a modest response. We think that the partial response 
could be related to the treatment of RA with MTX. However, the low, non-inflammatory range of synovial fluid WBCs raised the possibility 
that this effusion could be due to PDD, which has not been previously reported. 
Figure 5.A bone scan showed symmetrically increased radiotracer uptake 
involving the diaphyseal regions of the long bones of the upper and lower 
limbs (lower more than upper extremities). The cortex is differentiated from 
the medulla of the involved shafts of the long bones, but the ends of the long 
bones (metaphyso-epiphyseal regions) are not affected.
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